Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.452 EUR | +0.52% | -0.40% | -26.86% |
04-11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
03-26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.86% | 513M | |
+25.69% | 47.9B | |
+47.41% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Vaccine Developer Valneva Appoints New Chief Commercial Officer